Corporate News

OBS Medical celebrates the announcement of Excel Medical’s successful FDA clearance for their next generation clinical decision support platform – WAVE featuring Visensia®

Corporate News

Date Published: 10th January 2018

Abingdon, UK, 10th January 2018. OBS Medical limited, is pleased to celebrate the announcement of Excel Medical’s successful FDA clearance for their next generation patient surveillance platform WAVE, featuring Visensia® for the advanced prediction and prevention of patient deterioration.

Read More...

Visensia® Index integrated within Excel Medicals – next generation clinical decision support platform

Corporate News Product News

Date Published: 18th May 2017

Visensia Index integrated within Excel Medicals soon to be released next generation clinical decision support platform for the advanced and early detection of patient deterioration in acute care settings. Real Time Analysis & Alerting – Predictive Analytics.

Read More...

OBS Medical to attend HIMSS17 – Booth # 5881

Corporate News Product News

Date Published: 7th February 2017

OBS Medical will once again be attending the HIMSS annual conference and exhibition to showcase Visensia – The Safety Index for the advanced and early detection of patient deterioration. Highlights include – Dr James Whitticase presentation on Connexall Booth #1903 – “Intelligent Patient Monitoring – Better Outcomes”

Read More...

OBS Medical travels to Texas to promote UK Healthcare innovation

Corporate News Product News

Date Published: 24th October 2016

OBS Medical is part of a group of UK companies representing the country’s health and life science industry in Texas. Dr James Whitticase will be promoting Visensia – The Safety Index for the advanced detection of patient deterioration.

Read More...